Literature DB >> 34313962

Influencing factors for the decline of limb muscle strength and the association with all-cause mortality: evidence from a nationwide population-based cohort study.

Jiaxiang Gao1,2, Yudian Qiu3,4, Yunfei Hou1,2, Liyi Zhang1,2, Kai Wang1,2, Zhaoyu Chen1,2, Qian Liu1,2, Jianhao Lin5,6.   

Abstract

BACKGROUND: The decline of muscle strength, a typical characteristic of sarcopenia, greatly affects aging-related health outcomes; however, prospective data on influencing factors and mortality in the Chinese population are relatively sparse. AIMS: We investigated the influencing factors for the declined limb muscle strength and the association with all-cause mortality among the elderly Chinese individuals aged ≥ 65 years in a large long-term prospective cohort study.
METHODS: We used data from the China Health and Retirement Longitudinal Study (CHARLS). Logistic regression analyses were performed to investigate the influencing factors of declined limb muscle strength. Cox proportional hazard models were used to analyze the impact on all-cause mortality, whose performance was evaluated by train-test cross-validation.
RESULTS: The prevalences of declined upper and lower limb strength, which were defined by low hand grip strength (HS) and gait speed (GS), respectively, were 34.4% and 59.7%. The declined HS was significantly associated with older age (p < 0.001), female (p < 0.001), lower educational level (p < 0.001), lower BMI (p < 0.001), and combined with chronic diseases (p = 0.001). Moreover, the declined limb muscle strength was correlated with all-cause mortality (HR: 1.13, 95% CI 1.03-1.21 for HS; HR: 1.09, 95% CI 1.04-1.15 for GS), according to a multi-adjusted model with moderate predictive ability (C-index: 0.714, AUC of 7 year follow-up: 0.716).
CONCLUSIONS: The decline of limb muscle strength was prevalent among elderly Chinese individuals and had a strong impact on all-cause mortality. Identification of key populations and tailored interventions on their influencing factors should be implemented in further research.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  All-cause mortality; Gait speed; Hand grip strength; Influencing factors; Limb muscle strength; Sarcopenia

Mesh:

Year:  2021        PMID: 34313962     DOI: 10.1007/s40520-021-01940-w

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  38 in total

Review 1.  Sarcopenia.

Authors:  Alfonso J Cruz-Jentoft; Avan A Sayer
Journal:  Lancet       Date:  2019-06-03       Impact factor: 79.321

Review 2.  Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.

Authors:  Hunkyung Kim; Hirohiko Hirano; Ayako Edahiro; Yuki Ohara; Yutaka Watanabe; Narumi Kojima; Miji Kim; Erika Hosoi; Yuko Yoshida; Hideyo Yoshida; Shoji Shinkai
Journal:  Geriatr Gerontol Int       Date:  2016-03       Impact factor: 2.730

Review 3.  Sarcopenia: origins and clinical relevance.

Authors:  I H Rosenberg
Journal:  J Nutr       Date:  1997-05       Impact factor: 4.798

4.  Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort.

Authors:  Anne B Newman; Varant Kupelian; Marjolein Visser; Eleanor M Simonsick; Bret H Goodpaster; Stephen B Kritchevsky; Frances A Tylavsky; Susan M Rubin; Tamara B Harris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-01       Impact factor: 6.053

5.  Skeletal muscle and mortality results from the InCHIANTI Study.

Authors:  Matteo Cesari; Marco Pahor; Fulvio Lauretani; Valentina Zamboni; Stefania Bandinelli; Roberto Bernabei; Jack M Guralnik; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

6.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

7.  Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults.

Authors:  Ran Li; Jin Xia; X I Zhang; Wambui Grace Gathirua-Mwangi; Jianjun Guo; Yufeng Li; Steve McKenzie; Yiqing Song
Journal:  Med Sci Sports Exerc       Date:  2018-03       Impact factor: 5.411

Review 8.  Sarcopenia =/= dynapenia.

Authors:  Brian C Clark; Todd M Manini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-08       Impact factor: 6.053

Review 9.  Objective measures of physical capability and subsequent health: a systematic review.

Authors:  Rachel Cooper; Diana Kuh; Cyrus Cooper; Catharine R Gale; Debbie A Lawlor; Fiona Matthews; Rebecca Hardy
Journal:  Age Ageing       Date:  2010-09-15       Impact factor: 10.668

10.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gϋlistan Bahat; Jϋrgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-07-01       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.